Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis.

Norsworthy, Kelly J; Mulkey, Flora; Scott, Emma C; Ward, Ashley F; Przepiorka, Donna; Charlab, Rosane; Dorff, Sarah E; Deisseroth, Albert; Kazandjian, Dickran; Sridhara, Rajeshwari; Beaver, Julia A; Farrell, Ann T; de Claro, R Angelo; Pazdur, Richard

Norsworthy, Kelly J; Mulkey, Flora; Scott, Emma C; Ward, Ashley F; Przepiorka, Donna; Charlab, Rosane; Dorff, Sarah E; Deisseroth, Albert; Kazandjian, Dickran; Sridhara, Rajeshwari; Beaver, Julia A; Farrell, Ann T; de Claro, R Angelo; Pazdur, Richard.

Affiliation

Norsworthy KJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. kelly.norsworthy@fda.hhs.gov.
Mulkey F; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Scott EC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Ward AF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Przepiorka D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Charlab R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Dorff SE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Deisseroth A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Kazandjian D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Sridhara R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Beaver JA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Farrell AT; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
de Claro RA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.

Clin Cancer Res ; 26(16): 4280-4288, 2020 08 15.

Article de En | MEDLINE | ID: mdl-32393603

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe myéloïde / Isocitrate dehydrogenases Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Clin Cancer Res Sujet du journal: NEOPLASIAS Année: 2020 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google